| Malignant Lip Neoplasm studied in …STUDIED_INderived25 of 25show fewer |
|---|
| → studied in | NCT04333537Phase 2/Phase 3 · recruiting Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer · condition mapped ONTOLOGY_EXACT · 25 trials mapped (5 active) | — | — | Lip Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00568490recruiting Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers · condition mapped ALIAS · 25 trials mapped (5 active) | — | — | Malignant Lip Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02012699recruiting Integrated Cancer Repository for Cancer Research · condition mapped ALIAS · 25 trials mapped (5 active) | — | — | Malignant Lip Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05837221recruiting Microbiome in Head and Neck Squamous Cell Carcinoma · condition mapped ALIAS · 25 trials mapped (5 active) | — | — | Malignant Lip Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03174275Phase 2 · active not recruiting Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Carcinoma · condition mapped ALIAS · 25 trials mapped (5 active) | — | — | Malignant Lip Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03082534Phase 2 · completed Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma · condition mapped ALIAS · 25 trials mapped (5 active) | — | — | Lip Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07005115completed Serum Lipid Profile and Lip Squamous Cell Carcinoma · condition mapped ALIAS · 25 trials mapped (5 active) | — | — | Malignant Lip Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04985357withdrawn Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs · condition mapped ALIAS · 25 trials mapped (5 active) | — | — | Lip Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05610293unknown T1 Squamous Cell Carcinomas of the Lip · condition mapped ALIAS · 25 trials mapped (5 active) | — | — | Malignant Lip Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03602079Phase 1/Phase 2 · completed Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene · condition mapped CURATED_BROADER · 25 trials mapped (5 active) | — | — | Malignant Lip Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00470496Phase 1 · completed Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer · condition mapped CURATED_BROADER · 25 trials mapped (5 active) | — | — | Lip Basal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01084733completed Nicotine Levels With Response Rates to Radiation Alone or With Chemo In Head & Neck Cancer · condition mapped ALIAS · 25 trials mapped (5 active) | — | — | Malignant Lip Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01806675Phase 1/Phase 2 · completed 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy · condition mapped CURATED_BROADER · 25 trials mapped (5 active) | — | — | Lip Basal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02123511Phase 2 · completed Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy · condition mapped CURATED_BROADER · 25 trials mapped (5 active) | — | — | Lip Basal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00397384Phase 1 · completed Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer · condition mapped CURATED_BROADER · 25 trials mapped (5 active) | — | — | Lip Basal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00186433completed A Longitudinal Study of Plasma EBV DNA in Nasopharyngeal Carcinoma From Both Endemic and Non-Endemic Patient Populations · condition mapped ALIAS · 25 trials mapped (5 active) | — | — | Malignant Lip Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00101348Phase 1/Phase 2 · completed Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer · condition mapped CURATED_BROADER · 25 trials mapped (5 active) | — | — | Lip Basal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00492089Phase 2 · completed Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer · condition mapped CURATED_BROADER · 25 trials mapped (5 active) | — | — | Lip Basal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00031681Phase 1 · completed 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) · condition mapped CURATED_BROADER · 25 trials mapped (5 active) | — | — | Lip Basal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01155609NA · completed L-lysine in Treating Oral Mucositis in Patients Undergoing Radiation Therapy With or Without Chemotherapy For Head and Neck Cancer · condition mapped CURATED_BROADER · 25 trials mapped (5 active) | — | — | Lip Basal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00089362Phase 1 · completed Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors · condition mapped CURATED_BROADER · 25 trials mapped (5 active) | — | — | Lip Basal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00023959Phase 1 · completed Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer · condition mapped CURATED_BROADER · 25 trials mapped (5 active) | — | — | Lip Basal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00030498Phase 1 · completed Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction · condition mapped CURATED_BROADER · 25 trials mapped (5 active) | — | — | Lip Basal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00068497NA · completed Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer · condition mapped CURATED_BROADER · 25 trials mapped (5 active) | — | — | Lip Basal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01637194Phase 1 · completed Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cancer · condition mapped CURATED_BROADER · 25 trials mapped (5 active) | — | — | Lip Basal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |